Status:

RECRUITING

Repeatability of AO-SLO (Mona IIa) Technology and Cone Cell Density of Individuals Use Repeated Low-level Red-light Therapy

Lead Sponsor:

Ruihua Wei

Collaborating Sponsors:

Tianjin Medical University Eye Hospital

Conditions:

Myopia

Eligibility:

All Genders

6-55 years

Phase:

NA

Brief Summary

To explore the repeatability of AO-SLO (Mona IIa) technology and the difference of cone cell density between individuals who used or not used repeated low-intensity red light treatment

Detailed Description

This study focuses on the population with long-term use of repetitive low-intensity myopia, exploring the safety of repetitive low-intensity red light over a long period of use, and providing data sup...

Eligibility Criteria

Inclusion

  • 6 - 55 years old, gender not limited; Obtained informed consent.

Exclusion

  • Children with obvious strabismus and amblyopia
  • With congenital eye disease, such as congenital cataract, congenital retinal disease
  • Secondary myopia (such as premature retinopathy or other eye diseases in infants and children caused secondary myopia), or myopia combined with systemic syndrome (such as Marfan syndrome)
  • Had internal eye surgery (such as cataract extraction, intraocular lens implantation, anti-glaucoma surgery, etc.)
  • Refractive medium opacity (such as corneal disease, crystal opacity, etc.)
  • Bnormal intraocular pressure and clinical significance (IOP \<10 mmHg or IOP\>21mmHg or binocular IOP difference ≥5mmHg)
  • Fundus chorioretinopathy (except for high myopia fundus degenerative changes) or other intraocular diseases
  • Optic nerve damage or congenital optic nerve dysfunction
  • Can not be regularly checked
  • The adjustment range is less than 8D or obvious near difficulties
  • Other reasons researchers think it is not suitable for inclusion in researchers

Key Trial Info

Start Date :

September 20 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 20 2025

Estimated Enrollment :

180 Patients enrolled

Trial Details

Trial ID

NCT07160036

Start Date

September 20 2025

End Date

December 20 2025

Last Update

September 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tianjin Medical University Eye Hospital

Tianjin, Tianjin Municipality, China, 120120